The first FDA-approved psychedelic drug in U.S. history could hit the market next year. Compass Pathways COMP360 is…
The outpatient and interventional psychiatry market is experiencing dynamic shifts in access to care but still suffers from…
Behavioral health remains an attractive sector for investment and is in the early innings of consolidation. Key investor…
The COVID-19 crisis is shining a spotlight on demand for mental health services…
Behavioral health businesses, and in particular, ABA providers, that could clearly demonstrate embedded growth opportunities have achieved attractive valuations…
As we approach mid-May, many U.S. states are beginning to lift restrictions on COVID-19 lockdowns…
Recent efforts to repeal and replace the Affordable Care Act have been met with a lot of angst….
The healthcare M&A market is continuing to be a hotbed of activity, and increasingly dominated by consolidation of…